ClinicalTrials.gg
RecruitingNCT07162168Updated Dec 3, 2025

Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning

An observational study in Bone Aging and Osteoporosis Diagnosis, sponsored by Peking University People's Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-03.

Sponsored by Peking University People's Hospital · Observational

How we know

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 87 studies in Osteoporosis with a site in China — 27 open to participants now, 33 under way, 3 of them phase 3. Osteoporosis · China.

Planned enrollment
10th of 30
3,000 · median 1,750
Started
2024
with 9 others
Observational
30 of 87
12 open now
Primary completion
2027-09
later than 30 of 32 live
Registered
76th of 87
by date
Lead sponsor
2 of 87
Peking University People's Hospital

Among the 87 studies in Osteoporosis with a site in China, this one is the 10th largest by planned enrollment of the 30 observational ones that give a count, is one of 10 that started in 2024, is one of 30 observational ones, reaches primary completion later than 30 of the 32 other live ones, and was the 76th registered.

Osteoporosis

1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

Browse Osteoporosis studies →

Open to participants now

27 of the 87 studies in Osteoporosis with a site in China are open now. Recruiting first, the newest first:

21 more — sign in →

All 27 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 87 studies in Osteoporosis with a site in China, or all of them as a file.
02

Study summary

This study is a retrospective analysis that uses abdominal CT scans, which were originally taken for other medical reasons, to estimate bone age. By applying advanced deep learning methods, the investigators aim to develop a tool that can evaluate bone health and detect early signs of osteoporosis without requiring additional scans or radiation. This approach may help doctors better understand bone aging, improve screening for bone weakness, and provide patients with more personalized information about their bone health.

03

Conditions studied

  • Bone Aging
  • Osteoporosis Diagnosis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This retrospective study included about 3,000 adult participants (aged over 18 years) who underwent noncontrast abdominal CT scans that fully covered the proximal femur across multiple regions in China. Participants with poor image quality, prior hip surgery or internal fixation, bone tumors, severe hip deformities, or prior proximal femur fractures were excluded. All scans were performed for non-orthopedic indications. The study was approved by the Institutional Ethics Committee (approval number: 2024PHB388-001).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged over 18 years.
  • Underwent routine noncontrast abdominal CT scans.
  • CT scans fully included the proximal femur.
  • Scans were performed for non-orthopedic clinical indications.
  • Provided necessary demographic information (e.g., age, sex).

Exclusion criteria

Exclusion Criteria:

  • CT scans with poor image quality or severe artifacts that precluded accurate analysis.
  • History of hip surgery or presence of internal fixation devices.
  • Presence of bone tumors in the proximal femur.
  • Severe hip deformity or prior fractures affecting the proximal femur.
  • Pediatric patients or pregnant individuals (if applicable).
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
3,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Peking University People's Hospital cohort

    No intervention

  • Shandong Cohort

    No intervention

  • Canton Cohort

    No intervention

  • Guizhou cohort

    No intervention

  • Hunan Cohort

    No intervention

  • Inner Mongolia Cohort

    No intervention

  • Shaanxi Cohort

    No intervention

  • Shandong Cohort2

    No intervention

  • Other province Cohort

    No intervention

06

What researchers measure

Primary outcomes

  1. Radiomics-Based Bone Age Prediction Model

    Extraction of radiomics features from abdominal CT images of the proximal femur and development of a machine learning model to estimate biological bone age. The performance of the model will be evaluated by comparing predicted bone age with chronological age.

    Time frame: Retrospective analysis of CT scans acquired between Sep 01.2024 to Oct 01.2025

07

Study locations

1 of 1 sites recruiting
  • CT machine
    Beijing, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Our Research has not been finished yet.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Sep 2027, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2025
First posted
Sep 9, 2025
StartActual
Sep 1, 2024
Primary completionEst.
Sep 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Dec 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07162168
Responsible party
Yuhui Kou (Research Fellow, Peking University People's Hospital) — Principal investigator
First posted
Sep 9, 2025
Start date
Sep 1, 2024
Primary completion
Sep 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Dec 3, 2025

Study contacts

hanwen Cheng, M.D
Contact
chenghanwen1998@126.com
86-19541080926

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion